G. Mascellani

发表

Fractions of Chemically Oversulphated Galactosaminoglycan Sulphates Inhibit Three Enveloped Viruses: Human Immunodeficiency Virus Type 1, Herpes Simplex Virus Type 1 and Human Cytomegalovirus

A. di Caro, E. Perola, B. Bartolini, 1999, Antiviral chemistry & chemotherapy.

Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities.

A. Al-Hakim, R. Linhardt, J. Fareed, 1991, Biochemical pharmacology.

Structural modification induced in heparin by a Fenton-type depolymerization process.

G. Torri, E. Vismara, L. Liverani, 2007, Seminars in thrombosis and hemostasis.

Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions.

E. Dejana, G. Bazzoni, A. del Maschio, 1993, The Journal of laboratory and clinical medicine.

Heparins: Process-related physico-chemical and compositional characteristics, fingerprints and impurities

L. Liverani, G. Mascellani, Franco Spelta, 2009, Thrombosis and Haemostasis.

Titration of thioethers

G. Mascellani, C. Casalini, G. Cesarano, 1977 .

Heterogeneity of Unfractionated Heparins Studied in Connection with Species, Source, and Production Processes

L. Liverani, G. Mascellani, P. Bianchini, 1997, Seminars in thrombosis and hemostasis.

Characterization of di- and monosulfated, unsaturated heparin disaccharides with terminal N-sulfated 1,6-anhydro-beta-D-glucosamine or N-sulfated 1,6-anhydro-beta-D-mannosamine residues.

G. Torri, M. Guerrini, L. Liverani, 2007, Carbohydrate research.

Structure and contribution to the heparin cofactor II-mediated inhibition of thrombin of naturally oversulphated sequences of dermatan sulphate.

G. Torri, B. Casu, M. Guerrini, 1993, The Biochemical journal.

Susceptibility to highly sulphated glycosaminoglycans of human immunodeficiency virus type 1 replication in peripheral blood lymphocytes and monocyte-derived macrophages cell cultures.

A. di Caro, G. La Rosa, R. Cavallaro, 2003, Antiviral research.

Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II.

L. Liverani, G. Mascellani, P. Bianchini, 1996, Thrombosis research.

Low molecular weight heparins (5 kDa) and oligoheparins (2 kDa) produced by gel permeation enrichment or radical process: comparison of structures and physicochemical and biological properties.

N. Volpi, G. Mascellani, P. Bianchini, 1992, Analytical biochemistry.

Metabolites and analogs of 2-ethyl-2,3-dihydro-5-benzofuranacetic acid (furofenac): chemical and pharmacological properties.

G. Mascellani, A. Giumanini, C. Casalini, 1980, Journal of pharmaceutical sciences.

Synthesis and diuretic activity of imidazo[2,1-b]thiazole acetohydrazones

A. Andreani, M. Rambaldi, G. Mascellani, 1987 .

Quinolonecarboxylic acids. 2. Synthesis and antibacterial evaluation of 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acids.

G. Segre, V. Cecchetti, A. Fravolini, 1987, Journal of medicinal chemistry.

Synthesis and Cardiotonic Activity of 5,6-Disubstituted Imidazo(2,1-b)thiazoles.

A. Andreani, M. Rambaldi, G. Mascellani, 1987 .

Synthesis and antibacterial activity of some ester, amides, and hydrazides of 3-carboxyrifamycin S. Relationship between structure and activity of ansamycins.

E. Marchi, G. Mascellani, M. Brufani, 1981, Journal of Medicinal Chemistry.

4-Deoxypyrido[1',2':1,2]imidazo[5,4-c]rifamycin SV derivatives. A new series of semisynthetic rifamycins with high antibacterial activity and low gastroenteric absorption.

E. Marchi, L. Cellai, G. Mascellani, 1985, Journal of medicinal chemistry.

SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF SOME ESTERS, AMIDES, AND HYDRAZIDES OF 3-CARBOXYRIFAMYCIN S. RELATIONSHIP BETWEEN STRUCTURE AND ACTIVITY OF ANSAMYCINS

E. Marchi, G. Mascellani, M. Brufani, 1982 .

Semisynthetic chondroitins as chiral buffer additives in capillary electrophoresis.

R. Gotti, V. Andrisano, V. Cavrini, 1999, Journal of chromatography. A.

Free radical generation during chemical depolymerization of heparin.

A. Iannone, A. Tomasi, E. Vismara, 2005, Analytical biochemistry.

Relative influence of different disulphate disaccharide clusters on the HCII-mediated inhibition of thrombin by dermatan sulphates of different origins.

L. Liverani, G. Mascellani, P. Bianchini, 1994, Thrombosis research.

Dermatan sulfate as useful chiral selector in capillary electrophoresis.

R. Gotti, V. Andrisano, V. Cavrini, 1998, Journal of chromatography. A.

Spectrophotometric determination of pivampicillin hydrochloride.

G. Mascellani, E. Marchi, D. Boccali, 1974, Journal of pharmaceutical sciences.

Rectal absorption of some glycosaminoglycan sulphates and heparin in rats

G. Corbelli, G. Mascellani, P. Bianchini, 1981, The Journal of pharmacy and pharmacology.

Inhibition of human leukocyte elastase by chemically and naturally oversulfated galactosaminoglycans.

C. Bartolucci, E. Perola, D. Lamba, 1995, Carbohydrate research.

Low-molecular-weight heparin from Cu2+ and Fe2+ Fenton type depolymerisation processes

G. Torri, E. Vismara, M. Guerrini, 2010, Thrombosis and Haemostasis.

Application of Nonparametric Procedure for Bioassay Data to the Evaluation of Analgesics in Man

N. Ragni, G. Corvi, G. Mascellani, 1977, Journal of clinical pharmacology.

Active Sites of Dermatan Sulfate for Heparin Cofactor II. Isolation of a Nonasaccharide Fragment Containing Four Disaccharide Sequences [α-l-Iduronic Acid 2-O-Sulfate (1,3)-β-d-N-Acetylgalactosamine 4-Sulfate]

G. Torri, B. Casu, L. Silvestro, 1995 .

Stability of heparin and other fractions of glycosaminoglycan sulfates in human digestive juices.

G. Corbelli, G. Mascellani, M. Brufani, 1982, Journal of Pharmacy and Science.

Sepharose-bound, highly sulfated glycosaminoglycans can capture HIV-1 from culture medium.

C. Castilletti, A. di Caro, M. Capobianchi, 2005, Carbohydrate research.

Analytical techniques for studying structures of dermatan sulfate and low molecular weight dermatan sulfate

N. Volpi, G. Mascellani, L. Liverani, 1992 .

Extraction Methods of Glycosaminoglycans from Biologic Fluids

G. Mascellani, P. Bianchini, B. Parma, 1994, Seminars in thrombosis and hemostasis.

Oligo-Heparin Action on Endogenous Glycosaminoglycans. Pharmacokinetics: Direct and Mediated Effects

L. Liverani, G. Mascellani, P. Bianchini, 1994, Seminars in thrombosis and hemostasis.